Symbol="VRAX"
AssetType="Common Stock"
Name="Virax Biolabs Group Limited Ordinary Shares"
Description="Virax Biolabs Group Limited, a biotechnology company, sells, distributes and markets diagnostic test kits and medical technology products and PPE for the prevention, detection, diagnosis and risk management of viral diseases in the field of immunology. The company is headquartered in London, the United Kingdom."
CIK="1885827"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES"
Address="30 BROADWICK STREET, LONDON, GB"
FiscalYearEnd="March"
LatestQuarter="2023-03-31"
MarketCapitalization="7147200"
EBITDA="None"
PERatio="None"
PEGRatio="None"
BookValue="0.587"
DividendPerShare="0"
DividendYield="0"
EPS="-0.5"
RevenuePerShareTTM="0.001"
ProfitMargin="0"
OperatingMarginTTM="-669.64"
ReturnOnAssetsTTM="-0.727"
ReturnOnEquityTTM="-1.416"
RevenueTTM="8560"
GrossProfitTTM="-1365"
DilutedEPSTTM="-0.5"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="2"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="712.56"
PriceToBookRatio="-"
EVToRevenue="1133.86"
EVToEBITDA="-7.52"
Beta="None"
num_52WeekHigh="8.48"
num_52WeekLow="0.34"
num_50DayMovingAverage="0.397"
num_200DayMovingAverage="0.749"
SharesOutstanding="17890400"
DividendDate="None"
ExDividendDate="None"
symbol="VRAX"
open="0.41"
high="0.41"
low="0.39"
price="0.40"
volume="43948.00"
latest_trading_day="2023-08-07"
previous_close="0.41"
change="-0.01"
change_percent="-3.1280%"
aroon_positive_momentum_days="30"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Trending High"
value_analysis="Bullish Trend"
Aroon_change="FALSE"
Aroon_momentum="30"
Volume_recent_avg="427469"
Change_recent_avg="-0.01"
Delta_recent_avg="0.04"
Variance_recent_avg="0.02"
Change_ratio_recent_avg="-1.92"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="30"
Aroon_momentum_negative="70"
image_negative_thumbnail_id_1="1123"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0156.jpeg"
image_negative_thumbnail_id_2="1122"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0155.jpeg"
image_neutral_thumbnail_id_1="524"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0075.jpeg"
image_neutral_thumbnail_id_2="596"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0003.jpeg"
image_positive_thumbnail_id_1="972"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0134.jpeg"
image_positive_thumbnail_id_2="997"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0159.jpeg"
image_professor_thumbnail_id_1="1184"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0018.jpeg"
image_professor_thumbnail_id_2="1169"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0003.jpeg"
